The Antiviral and Antimalarial Prodrug Artemisinin from the Artemisia Species: A Review

Curr Issues Mol Biol. 2024 Oct 28;46(11):12099-12118. doi: 10.3390/cimb46110718.

Abstract

Artemisinin is a truly fascinating drug in many ways. Since the unrestrained procedure of its detection, as an antimalarial drug, artemisinin has received a great deal of consideration. Recently, application of artemisinin-based combination therapy has been broadly applied for treating numerous ailments. Moreover, as an antimalarial compound, artemisinin and its associated compounds have abundant healing efficacy and can be repurposed for additional symptoms, like autoimmune infections, cancer, and viral contaminations. Recently a number of studies have highlighted the significance of the artemisinin-related compounds in SARS-CoV-2 treatment. The current review purposes to present a concise account of the history of the antiviral and antimalarial prodrugs-Artemisinin, from the Artemisia species. It is followed by its antiviral, antimalarial prospective, chemical nature and extraction procedure, photochemistry, mechanism of action, and its clinical trials and patents, and accentuates the significance of the mechanistic studies concerned for therapeutic results, both in viral and malarial circumstances.

Keywords: Artemisia annua; antimalarial; antiviral; artemisinin; derivatives; prodrug.

Publication types

  • Review

Grants and funding

The authors are grateful to Dongguk University, Republic of Korea, for support.